PMLA POLICY | CAREERS | CIRCULAR | MEDIA CENTER | DOWNLOADS | CONTACT US | ISS TRADING HOLIDAYS | MEMBERS DOMAIN
Follow us:
m1 m3 m4 m5 m6 m7 m8
 
 
Tuesday, June 27, 2017 4:01:00 PM   
Adani Ports  367.250.56%
 
Asian Paints  1134.00-1.73%
 
Axis Bank  492.80-2.34%
 
Bajaj Auto  2779.20-1.61%
 
Bharti Airtel  371.801.61%
 
Cipla  534.90-1.10%
 
Coal India  244.75-0.26%
 
Dr Reddy's Lab..  2654.250.44%
 
H D F C  1654.900.25%
 
HDFC Bank  1667.90-0.63%
 
Hero Motocorp  3695.950.97%
 
Hind. Unilever  1092.15-0.40%
 
ICICI Bank  288.00-1.20%
 
Infosys  926.35-1.80%
 
ITC  311.750.29%
 
Kotak Mah. Ban..  974.30-1.13%
 
Larsen & Toubr..  1701.80-1.23%
 
Lupin  1064.000.30%
 
M & M  1369.90-0.45%
 
Maruti Suzuki  7191.40-0.63%
 
NTPC  157.65-0.13%
 
O N G C  159.951.23%
 
Power Grid Cor..  205.15-0.07%
 
Reliance Inds.  1435.900.06%
 
St Bk of India  279.40-3.27%
 
Sun Pharma.Ind..  543.65-0.06%
 
Tata Motors  441.55-0.35%
 
Tata Motors-DV..  274.50-0.49%
 
Tata Steel  510.450.60%
 
TCS  2345.90-0.62%
 
Wipro  256.00-0.33%
 
 ««-1
Hot Pursuit
Home > Equity > News >  Hot Pursuit
  Back
Panacea Biotec gains on selling 100% stake in arm
(21-Apr-2017, 14:29 Hours IST)  
The announcement was made during trading hours today, 21 April 2017.

Meanwhile, the S&P BSE Sensex was down 99.99 points, or 0.34% to 29,322.40.

On the BSE, 1.18 lakh shares were traded in the counter so far, compared with average daily volumes of 41,335 shares in the past one quarter. The stock had hit a high of Rs 174.40 and a low of Rs 156.20 so far during the day.

The stock hit a 52-week high of Rs 178.30 on 27 January 2017. The stock hit a 52-week low of Rs 85.50 on 26 May 2016.

The stock had outperformed the market over the past one month till 20 April 2017, rising 4.02% compared with 0.87% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 8.71% as against Sensex's 8.83% rise.

The small-cap company has equity capital of Rs 6.13 crore. Face value per share is Re 1.

Panacea Biotec has entered into a definitive agreement to divest its 100% stake held in NewRise Healthcare (NHPL) which has set up a multi-speciality hospital at Gurugram which is near completion to Narayana Hrudayalaya. Under the definitive agreement, Panacea Biotec has agreed to sell its 100% equity share in NHPL to Narayana Hrudayalaya. Panacea Biotec's associate company PanEra Biotec has agreed to sell 100% preference shares in NewRise Healthcare to Narayana Hrudayalaya.

Shares of Narayana Hrudayalaya were up 0.03% at Rs 318.45.

Panacea Biotec reported net loss of Rs 29.25 crore in Q3 December 2016, higher than net loss of Rs 17.38 crore in Q3 December 2015. Net sales declined 34% to Rs 99.33 crore in Q3 December 2016 over Q3 December 2015.

Panacea Biotec is one of India's leading research based biotechnology companies with established research, manufacturing and marketing capabilities.

Powered by Capital Market - Live News

IMPORTANT LINKS QUICK LINKS
DISCLAIMER
PRIVACY POLICY
SITEMAP
BSE DISCLAIMER
BSE INVESTOR COMPLAINT
PMLA POLICY
CAREERS
CIRCULAR
MEDIA CENTER
DOWNLOAD
CONTACT US
ISE SPECIAL OFFER
BSE
NSE
ISE
SEBI
CDSL
NSDL
RBI
AMFI
MOF
MCX
NCDEX
FMC
VERNACULAR LANGUAGE
FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com
BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737<br /> ISE Securities & Services Ltd. (ISS), a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)
© 2013 ISE Securities & Services Limited. All rights reserved.
Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)